Congressional Investigation of Alzheimer’s Drug Aduhelm Fails the FDA and Biogen
The FDA’s own internal investigation said there was “no evidence” that interactions with Biogen were “anything but appropriate” given the complexity of the data and… Read More »Congressional Investigation of Alzheimer’s Drug Aduhelm Fails the FDA and Biogen